Loading...
•
Mar 31, 2020
Rigel Q1 2020 Earnings Report
Rigel reported first quarter results, including net product sales of $12.7 million and collaboration revenues of $43.1 million.
Key Takeaways
Rigel Pharmaceuticals reported a net income of $21.2 million for the first quarter of 2020, with total revenues of $55.8 million, including $12.7 million in net product sales and $43.1 million in contract revenues from collaborations.
Net product sales increased 57% year over year to $12.7 million.
Collaboration revenues reached $43.1 million due to milestone payment from Grifols.
41 patients enrolled in pivotal Phase 3 clinical trial in warm AIHA.
Received $10.0 million in funding from existing credit facility.
Revenue by Segment
Forward Guidance
Rigel is exploring opportunities for earlier stage programs and believe that they can finalize a collaboration by year end.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...